BridgeMD
New treatment option for Type2 Diabetes
Official title STOP DIABETES - Knowledge-based Solutions
ClinicalTrials.gov ID: NCT03156478
What this study is testing
- What it's testing
- The aim of the Stop Diabetes - Knowledge based solutions (StopDia) consortium project (University of Eastern Finland, National Institute for Health and Welfare, and Technical Research Centre of Finland) is to develop and test approaches to identify individuals at increased risk of type 2 diabetes and to empower them in adopting and maintaining a healthy lifestyle by combining individual and environment level strategies into a dual-process approach targeting deliberative and automatic processes of behavior. We also aim to identify barriers and facilitators of adopting a healthy lifestyle in the society, create a model for the prevention of type 2 diabetes by joint actions of health care, third sector, and other societal actors, and develop methods to monitor the cost-effectiveness of these actions.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70. Healthy volunteers may be eligible.
You may be able to join if
- age of 18-70 years
- 12 points or more in the Finnish diabetes risk score or previous gestational diabetes or repeated impaired fasting glucose (IFG) (fasting plasma...
- living in the hospital district of Northern Savo, Päijät-Häme or South Karelia
- possibility to use computer, smartphone or tablet with internet connection
- having own self-phone number
You likely can't join if
- type 1 or 2 diabetes
- pregnancy or breastfeeding
- current cancer or less than 6 months from the end of cancer treatment
See the full eligibility criteria
- age of 18-70 years
- 12 points or more in the Finnish diabetes risk score or previous gestational diabetes or repeated impaired fasting glucose (IFG) (fasting plasma glucose level 6,1 - 6,9 mmol/l) or impaired glucose tolerance (2-hour...
- living in the hospital district of Northern Savo, Päijät-Häme or South Karelia
- possibility to use computer, smartphone or tablet with internet connection
- having own self-phone number
- adequate Finnish language skill
- type 1 or 2 diabetes
- pregnancy or breastfeeding
- current cancer or less than 6 months from the end of cancer treatment
The study team makes the final eligibility decision.
Where it's taking place
- Kuopio, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kuopio, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.